Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
about
T cells in atherosclerosisInhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic miceImmunity, atherosclerosis and cardiovascular diseaseCD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptideB cells and atherosclerosis.Vaccine against arteriosclerosis: an update.CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice.Immunomodulation of vascular diseases: atherosclerosis and autoimmunityInflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ miceImmunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null miceImmunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.Vaccination to modulate atherosclerosisImmunomodulation and vaccination for atherosclerosis.Metabolic syndrome: the danger signal in atherosclerosis.Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.Influenza and atherosclerosis: vaccination for cardiovascular disease prevention.Beyond vascular inflammation--recent advances in understanding atherosclerosis.Immune response to lipoproteins in atherosclerosis.Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?Immunomodulation of atherosclerosis with a vaccine.Targeting activation of specific NF-κB subunits prevents stress-dependent atherothrombotic gene expression.A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approachLack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein EAutoimmunity in atherosclerosis: a protective response losing control?2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in AtherosclerosisAssociations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetesImmune mechanisms in atherosclerosis, especially in diabetes type 2Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.T-Cells Specific for a Self-Peptide of ApoB-100 Exacerbate Aortic Atheroma in Murine Atherosclerosis.Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseasesAtherosclerosis, diabetes and lipoproteins.Progress and future opportunities in the development of vaccines against atherosclerosis.Vaccines against atherosclerosis.Can we vaccinate against atherosclerosis?Multiple potential roles for B cells in atherosclerosis.Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects
P2860
Q27025697-EE159BB5-C11A-45FD-A1AC-DEEBD5A7A8A8Q27317653-4907FC23-95F8-48CD-915E-4EDE971DEE99Q28688590-7BA8005E-BC3F-4642-859E-9E93D02311EBQ28732168-520F957F-BC27-47D2-B127-DA4832A9DE20Q30252928-44ECC483-1282-44EE-B270-F2E85D7889C7Q33641227-90F678AF-DB9C-425B-A4D5-35EA9C5B4268Q33761718-F1ECEE57-F16D-4193-ACE7-CD4F15E8621BQ33770999-8FDA8D2F-9267-443D-AB06-FBB0998CAB2DQ33805176-0E8108EF-D90D-4334-B771-99DC7BE66244Q34513915-ED16D88C-17B6-4BFF-AAAA-30121F028818Q34528035-3DE2EDE0-40C5-46E8-BEA0-7BB408B1FB6CQ35069480-5CEF0592-73B7-40BD-AA30-4683384729C3Q35174901-A25C6833-DB24-4325-A25A-87B70B159D2FQ35175305-FE620769-4B18-4497-A0D4-4C6EF5B9B080Q35600876-0063CCC0-A4FB-4205-A5AF-B141364A12BDQ35753555-6D2BF66E-E557-45C9-B538-C8CF0650B898Q36012953-405D2052-AEC4-4B9A-A816-DEB46864CAC2Q36020265-2BF3AC86-F56F-4028-B9AF-65D371E0D5CAQ36040828-46729CE0-EC3D-4719-9600-F7A45EC835B7Q36079808-AD09495D-64A3-49CF-9279-5F3045EADB7EQ36203882-6CD22B12-4995-4A5B-AEDC-7B95E880F420Q36279562-70AFB2A3-20B8-41E2-B3C3-C87C9144A7CCQ36283424-28228010-FBBB-46AA-8FF1-3445F0F6E7C5Q36321769-F2D0807B-9805-41B0-8BFD-4A9EDD70FD34Q36498317-B426E9D5-49C5-4C72-A3E8-61362A6F0493Q36547962-366CCF6F-B8A9-4680-9ECB-DEEF3BCC4DBCQ36986664-13BE5801-1FC3-4E9F-9D6D-5FA3EC5E3B8FQ37138017-F5294411-0407-41BB-9157-D73BEB4BD408Q37146276-FC99EAF5-3601-49C1-9F3B-1F1F555CBEB5Q37207913-925D9529-ABA7-4C29-85AB-C61E177BFFCBQ37261617-0E7D9EC8-E7C0-4101-B4C2-F3973B7DF84AQ37415733-8C074B2F-5D36-4022-95D9-0E23C12D85CBQ37660865-005CECDA-E47F-4F06-A0DF-AEBA9DE95B43Q37709623-B014AD51-B7F6-4B3D-9EB3-E8C474FE4CA0Q37770113-7F52C1D0-9335-47BF-B849-0BF8F60C6B8EQ37835406-AC5B71A5-9E4F-47A7-86DA-3BF18EE6B7D6Q38089941-EF19BA35-F4EC-4CBC-A6ED-F529A13044A1Q38137846-2559E61A-14EE-4967-B7D7-01B09D4A8B10Q38210609-7471677F-C605-4048-9790-031F76F1C1C4Q38218096-E46AC7CF-05D7-4F30-975A-B3DAECB20684
P2860
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inhibition of atherosclerosis ...... th apoB-100 peptide sequences.
@ast
Inhibition of atherosclerosis ...... th apoB-100 peptide sequences.
@en
type
label
Inhibition of atherosclerosis ...... th apoB-100 peptide sequences.
@ast
Inhibition of atherosclerosis ...... th apoB-100 peptide sequences.
@en
prefLabel
Inhibition of atherosclerosis ...... th apoB-100 peptide sequences.
@ast
Inhibition of atherosclerosis ...... th apoB-100 peptide sequences.
@en
P2093
P1476
Inhibition of atherosclerosis ...... th apoB-100 peptide sequences.
@en
P2093
Gunilla Nordin Fredrikson
Ingrid Söderberg
Jan Nilsson
Kuang-Yuh Chyu
Paul Dimayuga
Prediman K Shah
P304
P356
10.1161/01.ATV.0000067937.93716.DB
P407
P577
2003-03-20T00:00:00Z